Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03050151 · ClinicalTrials.gov registry record · Phase 1
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
A Phase 1 study, sponsored by Regeneron Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 176
- Enrollment target
NCT03050151: Completed Phase 1 study, sponsored by Regeneron Pharmaceuticals.
NCT03050151 is a Phase 1 study that has completed, run by Regeneron Pharmaceuticals. The registered enrollment target is 176 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (193% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03050151, a Phase 1 study, has completed, sponsored by Regeneron Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 176 participants
- Enrollment target
Study Summary
To collect data on actual-use to assess technical performance and user injections of dupilumab auto-injection device by patients with atopic dermatitis (AD).
Interventions
- DRUG Dupilumab
- DEVICE Auto-injector Device
- DEVICE Prefilled syringe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2017-02-28 |
| Est. Completion | 2018-02-12 |
| Phase | Phase 1 |
What the finished NCT03050151 record still lists
NCT03050151 is an interventional study that assigns participants to a tested intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (193% higher).
The record links to 0 conditions, and to 3 interventions - of which Dupilumab is the first listed.
NCT03050151 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03050151 about?
NCT03050151 is a clinical study titled "Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis". To collect data on actual-use to assess technical performance and user injections of dupilumab auto-injection device by patients with atopic dermatitis (AD).
What is the current status of trial NCT03050151?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 176 participants. The study started on 2017-02-28. Estimated completion is 2018-02-12.
What interventions are being tested in trial NCT03050151?
The interventions under investigation include: Dupilumab (DRUG), Auto-injector Device (DEVICE), Prefilled syringe (DEVICE).
Who is sponsoring clinical trial NCT03050151?
This trial is sponsored by Regeneron Pharmaceuticals, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03050151's enrollment target sits among peer trials
176 316th of 2000 higher than 1,682 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI